GlassScriptPhysician profile
Mark G Buchanan
NPI 1104825637
$7,521.75
in general payments reported to CMS, 2019-2025
57 companies · $1,605 in 2025
The $1,605 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,150 · 2020: $541 · 2021: $1,270 · 2022: $915 · 2023: $1,259 · 2024: $782 · 2025: $1,605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,611 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,610.70 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $890.03 | 2019-2025 | Myrbetriq, Xtandi |
| Medtronic, INC. | $590.23 | 2021-2025 | Interstim |
| Teleflex LLC | $498.57 | 2021-2025 | Urolift, Barrigel |
| Endo Pharmaceuticals INC. | $450.50 | 2019-2024 | Xiaflex |
| Coloplast Corp | $417.47 | 2019-2025 | Titan |
| Sumitomo Pharma America, INC. | $336.46 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $296.01 | 2020-2024 | Ams 700, Advance Xp, Rezum Generator |
| Dendreon Pharmaceuticals LLC | $295.03 | 2019-2025 | Provenge |
| Pfizer INC. | $281.86 | 2019-2025 | |
| Antares Pharma, INC. | $238.46 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Olympus America INC. | $235.43 | 2024-2025 | Itind System |
| Angiodynamics, INC. | $210.41 | 2023 | Nanoknife |
| Janssen Biotech, INC. | $200.72 | 2019-2025 | Erleada |
| Axonics, INC. | $167.46 | 2020-2024 | Axonics |
| Merck Sharp & Dohme LLC | $120.67 | 2020-2025 | Lynparza, Keytruda, Welireg |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Buchanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.